Repeat revascularization isn’t a rare occurrence after PCI or CABG, according to a study of patients with left main coronary artery disease—but it can raise a person’s risk of cardiovascular death by as much as four times.

The FDA has approved a Medtronic-run trial, PULSED AF, to evaluate the safety and efficacy of new tech that uses pulsed electric fields to treat AFib.

Burnout may increase a person’s risk of developing atrial fibrillation by as much as 20%, researchers reported this month in the European Journal of Preventive Cardiology.

A possible shortage of heparin, one of the most popular blood thinners on the market, is threatening the U.S., according to a viewpoint published in The Lancet on Jan. 23.

Injection drug users prescribed controlled release hydromorphone—an opioid—are three times more likely to develop endocarditis than users prescribed other opioids, according to work published Jan. 22 in The Lancet Infectious Diseases.

The jury is out: vaping, or e-cigarette use, is a national epidemic in the U.S.

Palo Alto, Calif.-based nonprofit Additional Ventures announced Jan. 21 it would be awarding a total of $5.7 million to five institutions for research on single ventricle heart defects.

A recent meta-analysis published in the Journal of Vascular and Interventional Radiology supports evidence that paclitaxel-coated balloons may pose more risk than reward for patients with symptoms of critical limb ischemia.